Skip to main content

Table 2 The incidence of erythrocytosis and polyglobulia (based on haematology parameters measured in 2012) in C1-INH-HAE patients who have never been treated with danazol, vs. in healthy controls

From: The effect of long-term danazol treatment on haematological parameters in hereditary angioedema

   C1-INH-HAE patients never treated with danazol (n = 51) Healthy controls (n = 210)
Erythrocytosis Males 0 2
Females 1 6
No erythrocytosis Males 21 87
Females 29 115
Polyglobulia Males 0 0
Females 0 1
No polyglobulia Males 21 89
Females 30 120
\